Clinical Trials in Denver

Showing 8341-8360 of 18,161 trials

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

NCT01416428

The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

Multiple MyelomaWaldenstrom Macroglobulinemia

Amgen210 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Salinas, California, United States • Denver, Colorado, United States +16 more locations

COMPLETEDPhase 3< 1 mile

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

NCT00358215

The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.

Heart FailureAnemiaCardiovascular Disease+2 more

Amgen2,278 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +751 more locations

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Find Trials by Condition in Denver

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

Virtual Sun Safe Workplaces Ph I

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer